All Algorithms Used Showed That CD13 Could Contribute to Discrimination Between Acute Myeloid Leukemia Blasts and Normal Myeloid Hematopoietic Precursors Among the Additional Markers in Tube 1. The gene discussed is ANPEP; the disease is leukemia.